Dermapharm Holding SE (ETR:DMP)
Germany · Delayed Price · Currency is EUR 38.30
-0.50 (-1.29%)
Sep 10, 2026, 5:35 PM CET
Dermapharm Holding SE Financials Overview
Financials in millions EUR. Fiscal year is January - December.
Millions EUR. Fiscal year is Jan - Dec.
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Revenue Revenue Growth | 1,182 | 1,166 | 1,182 | 1,136 | 1,025 | 943.4 |
Revenue Growth | 0.40% | -1.32% | 4.03% | 10.80% | 8.65% | 18.74% |
Gross Profit Gross Profit Growth | 773.39 | 753.25 | 735.91 | 689.18 | 633.18 | 593.54 |
Operating Income Operating Income Growth | 249.01 | 236.62 | 222.07 | 193.16 | 282.72 | 295.91 |
Net Income Net Income Growth | 146.54 | 132.41 | 113.79 | 62.37 | 134.24 | 209.58 |
Earnings Per Share EPS Growth | 2.77 | 2.46 | 2.11 | 1.16 | 2.49 | 3.89 |
EPS Growth | 39.03% | 16.37% | 82.45% | -53.54% | -35.91% | 144.65% |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Branded Pharmaceuticals Branded Pharmaceuticals Growth | 664.96 | 629.16 | 589.43 | 537.44 | 629.69 | - |
Other Healthcare Products Other Healthcare Products Growth | 358.94 | 363.84 | 369.96 | 402.33 | 180.67 | - |
Parallel Import Business Parallel Import Business Growth | 188.63 | 203.44 | 249.15 | 235.49 | 244.94 | 230.63 |
Reconciliation/Group Holding Company Reconciliation/Group Holding Company Growth | -31.14 | -31.45 | -27.77 | -39.91 | -30.52 | -1.48 |
Total Total Growth | 1,181 | 1,165 | 1,181 | 1,135 | 1,025 | 942.91 |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Investments Cash & Investments Growth | 195.56 | 204.46 | 121.9 | 159.54 | 152.5 | 163.18 |
Total Debt Total Debt Growth | 1,169 | 1,058 | 990.26 | 1,094 | 516.45 | 580.3 |
Net Cash (Debt) Net Cash Growth | -973.45 | -853.46 | -868.36 | -934.03 | -363.95 | -417.13 |
Net Cash Growth | - | - | - | - | - | - |
Net Cash Per Share Net Cash Per Share Growth | -18.41 | -15.85 | -16.13 | -17.35 | -6.76 | -7.75 |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Operating Cash Flow Operating Cash Flow Growth | 264.34 | 229.15 | 201.38 | 219.42 | 288.53 | 250.37 |
Capital Expenditures CapEx Growth | -48.39 | -42.12 | -38.24 | -41.54 | -39.01 | -61.2 |
Free Cash Flow Free Cash Flow Growth | 215.96 | 187.03 | 163.14 | 177.88 | 249.52 | 189.17 |
Free Cash Flow Growth | 23.16% | 14.64% | -8.29% | -28.71% | 31.91% | 109.48% |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Gross Margin | 65.41% | 64.61% | 62.29% | 60.68% | 61.77% | 62.91% |
Operating Margin | 21.06% | 20.29% | 18.80% | 17.01% | 27.58% | 31.37% |
Pretax Margin | 16.30% | 15.74% | 14.56% | 9.33% | 21.10% | 31.06% |
Profit Margin | 12.39% | 11.36% | 9.63% | 5.49% | 13.10% | 22.22% |
FCF Margin | 18.27% | 16.04% | 13.81% | 15.66% | 24.34% | 20.05% |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Sep '26 Sep 11, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Dividend Per Share Dividend Per Share Growth | 0.880 | 0.880 | 0.900 | 0.880 | 1.050 | 2.170 |
Dividend Per Share Growth | -2.22% | -2.22% | 2.27% | -16.19% | -51.61% | 146.59% |
Dividend Yield | 2.24% | 2.28% | 2.42% | 2.23% | 3.07% | 2.79% |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Sep '26 Sep 11, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
PE Ratio | 13.82 | 16.00 | 18.41 | 36.55 | 15.05 | 22.94 |
Forward PE | 13.73 | 15.94 | 16.66 | 17.44 | 10.61 | 22.27 |
P/FCF Ratio | 8.79 | 11.33 | 12.84 | 12.82 | 8.10 | 25.42 |
PS Ratio | 1.60 | 1.82 | 1.77 | 2.01 | 1.97 | 5.10 |